Literature DB >> 10974161

Autoimmunity and malaria: what are they doing together?

C T Daniel-Ribeiro1, G Zanini.   

Abstract

A common feature of autoimmunity is the presence of autoantibodies (AAb). Two types of AAb have been described: the 'pathogenic' AAb, associated with autoimmune diseases (AID), and the so-called 'natural' AAb. The latter are present in all normal individuals and have been postulated to play a major role as a first defensive barrier of the organism. Both the 'pathogenic' and the 'natural' AAb can be detected at higher frequencies among individuals exposed to viral, bacterial and parasitic infections. The malaria associated AAb do not seem to result from a generalised polyclonal B-cell activation (PBA), have specificities that may differ according to the degree of clinical immunity and do not seem to be pathogenic. Malaria may offer a protective effect against AID, by diminishing its severity or by either preventing or retarding its expression. AAb could also participate in the immune protection against malaria, and this could happen in several ways: (i) AAb directed to modified Ag expressed on the red blood cell (RBC) membrane during parasitisation and (ii) AAb reactive with crypto- or neo-Ag revealed on both normal and infected RBC membranes, by destroying infected, and also normal, erythrocytes; (iii) anti-idiotype AAb specific of the binding site of anti-merozoite Ab, which would mimic the parasite ligand for the RBC receptor, by competing with parasites and blocking RBC invasion; (iv) AAb cross-reactive with parasite material - such as nuclear or cytoskeleton Ag - having a direct parasiticide activity; (v) the natural AAb network, through its 'anti-bacterial first defense barrier'; and finally (vi) anti-phospholipid (PL) AAb, by neutralizing the pathogenic properties of parasite-derived PL. Finally, in view of currently available knowledge, it is concluded that, since AAb are not always pathogenic, the price for an 'autoimmunity-mediated' protection in malaria would not necessarily be immunopathology and clinical autoimmunity, and a protective role of AAb could be exerted with no danger to the host.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974161     DOI: 10.1016/s0001-706x(00)00099-1

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  28 in total

1.  Effects of anti-endothelial cell antibodies in leprosy and malaria.

Authors:  Christophe Dugué; Ronald Perraut; Pierre Youinou; Yves Renaudineau
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  The association of anti-phospholipid antibodies with parity in placental malaria.

Authors:  S Owens; L W Chamley; J Ordi; B J Brabin; P M Johnson
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  The prevalence of autoantibodies in an elderly sub-Saharan African population.

Authors:  R Njemini; I Meyers; C Demanet; J Smitz; M Sosso; T Mets
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

4.  High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals.

Authors:  P H Consigny; B Cauquelin; P Agnamey; E Comby; P Brasseur; J J Ballet; C Roussilhon
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  The Regulation of Inherently Autoreactive VH4-34-Expressing B Cells in Individuals Living in a Malaria-Endemic Area of West Africa.

Authors:  Geoffrey T Hart; Munir Akkaya; Asiya S Chida; Chungwen Wei; Scott A Jenks; Christopher Tipton; Chenfeng He; Ben S Wendel; Jeff Skinner; Gunjan Arora; Kassoum Kayentao; Aissata Ongoiba; Ogobara Doumbo; Boubacar Traore; David L Narum; Ning Jiang; Peter D Crompton; Ignacio Sanz; Susan K Pierce
Journal:  J Immunol       Date:  2016-10-19       Impact factor: 5.422

Review 6.  Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review.

Authors:  Nurullah Akkoc
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 7.  Young lives lost as B cells falter: what we are learning about antibody responses in malaria.

Authors:  Silvia Portugal; Susan K Pierce; Peter D Crompton
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

8.  The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections.

Authors:  Greta E Weiss; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; Seydou Dia; Agnes Guindo; Abdramane Traore; Chiung-Yu Huang; Kazutoyo Miura; Marko Mircetic; Shanping Li; Amy Baughman; David L Narum; Louis H Miller; Ogobara K Doumbo; Susan K Pierce; Peter D Crompton
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

9.  Autoimmune thyroid diseases in patients with chronic fasciolosis.

Authors:  Mustafa Demirci; S Ercan Tunc; Namik Delibas; M Numan Tamer; Irfan Altuntas; Metin Korkmaz
Journal:  Wien Klin Wochenschr       Date:  2003-03-31       Impact factor: 1.704

10.  Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region.

Authors:  Andréa Aparecida Morais Fernandes; Leonardo José de Moura Carvalho; Graziela Maria Zanini; Ana Maria Revorêdo da Silva Ventura; José Maria Souza; Paulo Marcelo Cotias; Isaac Lima Silva-Filho; Cláudio Tadeu Daniel-Ribeiro
Journal:  Clin Vaccine Immunol       Date:  2008-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.